Peripheral blood stem cell source is feasible in haploidentical transplantation.
The 2-step approach allows separate control over the graft T cell and stem cell doses.
Early immune recovery was seen in both haploidentical and matched related groups.
Clinical outcomes were comparable between haploidentical and matched related groups.
Grade 2 acute graft-versus-host disease was higher in the haploidentical group.
© 2004-2018 中国地质图书馆版权所有 京ICP备05064691号 京公网安备11010802017129号 地址:北京市海淀区学院路29号 邮编:100083 电话:办公室:(+86 10)66554848;文献借阅、咨询服务、科技查新:66554700 |